Home » Stocks » BLI

Berkeley Lights, Inc. (BLI)

Stock Price: $46.76 USD -0.12 (-0.26%)
Updated Apr 20, 2021 4:00 PM EDT - Market closed
After-hours: $47.50 +0.74 (1.58%) Apr 20, 5:58 PM
Market Cap 3.06B
Revenue (ttm) 64.30M
Net Income (ttm) -41.58M
Shares Out 31.19M
EPS (ttm) -1.39
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day April 20
Last Price $46.76
Previous Close $46.88
Change ($) -0.12
Change (%) -0.26%
Day's Open 46.96
Day's Range 45.29 - 47.58
Day's Volume 457,952
52-Week Range 42.03 - 113.53

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Other stocks mentioned: CERN, JKHY, RUN, SBNY, SI, WCN
6 days ago - GuruFocus

EMERYVILLE, Calif., April 12, 2021 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today announced the company will be reporting financial results for the firs...

1 week ago - GlobeNewsWire

These seven stocks may be risky, but they also have the potential for big returns -- as all of them are stocks that could double by summer. The post 7 Stocks That Could Double by Summer appeared first o...

Other stocks mentioned: ATRA, CGEN, CIDM, CRDF, KERN, ZDGE
2 weeks ago - InvestorPlace

EMERYVILLE, Calif., April 05, 2021 (GLOBE NEWSWIRE) -- Today, Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, announced the launch of Opto Assure, a series of assays that provides...

2 weeks ago - GlobeNewsWire

EMERYVILLE, Calif., March 16, 2021 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today announced the company will be participating in the upcoming KeyBanc Li...

1 month ago - GlobeNewsWire

An important indicator for investors to consider could be a stock's 52-week trading range, the range shows the lowest and highest price that a particular stock has traded at over the last trailing 52 we...

Other stocks mentioned: ARRY, DASH
1 month ago - Benzinga

EMERYVILLE, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today announced the company will be participating in the upcoming Cowen 41st ...

1 month ago - GlobeNewsWire

Berkeley Lights (BLI) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

2 months ago - Zacks Investment Research

Kurt Wood appointed CFO; Industry Veterans Pete Leddy, as CHRO, and Mimi Healy, as CPO, join Berkeley Lights

2 months ago - GlobeNewsWire

EMERYVILLE, Calif., Jan. 12, 2021 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today announced the Opto™ Plasma B Discovery 4.0 workflow. Opto Plasma B Disc...

3 months ago - GlobeNewsWire

EMERYVILLE, Calif., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today announced the company will be participating in the upcoming 39th Annual...

3 months ago - GlobeNewsWire

Berkeley Lights (BLI) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

3 months ago - Zacks Investment Research

EMERYVILLE, Calif., Nov. 18, 2020 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc., a leader in Digital Cell Biology, today announced the pricing of its previously announced public offering of 3,000,000 shares...

5 months ago - GlobeNewsWire

EMERYVILLE, Calif., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc., a leader in Digital Cell Biology, today announced the launch of a public offering of 3,000,000 shares of common stock to be s...

5 months ago - GlobeNewsWire

Berkeley Lights, Inc. (BLI) CEO Eric Hobbs on Q3 2020 Results - Earnings Call Transcript

5 months ago - Seeking Alpha

EMERYVILLE, Calif., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today reported financial results for the quarter ended September 30, 2020.

5 months ago - GlobeNewsWire

EMERYVILLE, Calif., Oct. 19, 2020 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today announced the company will be report financial results for the third qu...

6 months ago - GlobeNewsWire

Eric Hobbs discusses how Berkeley Lights is not just fighting COVID-19, but also accelerating the design-build-test cycle for all of synthetic biology.

7 months ago - Forbes

MIAOLI, Taiwan and EMERYVILLE, Calif., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Mycenax Biotech, Inc. (4726.TWO), a pioneer of biopharmaceutical development in Taiwan, today announced its adoption of the Be...

7 months ago - GlobeNewsWire

EMERYVILLE, Calif., Sept. 01, 2020 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today announced the company will be participating in the upcoming Morgan S...

7 months ago - GlobeNewsWire

EMERYVILLE, Calif., Aug. 25, 2020 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today reported financial results for the quarter ended June 30, 2020.

7 months ago - GlobeNewsWire

EMERYVILLE, Calif., July 21, 2020 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc., (Nasdaq: BLI) a leader in Digital Cell Biology, today announced the closing of its initial public offering of 9,315,000 sha...

8 months ago - GlobeNewsWire

Shares of Berkeley Lights Inc. BLI, +134.09% took flight Friday, as the cell biology company went public at a price that was more than double what the upsized initial public offering was priced.

9 months ago - Market Watch

Berkeley Lights Inc. raised $178.2 million as the cell biology company's upsized initial public offering priced above the expected range.

9 months ago - Market Watch

About BLI

Berkeley Lights, Inc., a digital cell biology company, focuses on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products. The company offers an integrated platform, which comprise of proprietary consumables, including OptoSelect chips and reagent kits, automation systems, and application and workflow software. It serves in North America, the Asia Pacific, and Europe. The company was incorporated in 2011 and is headquartered in Emeryville, California.

Industry
Biotechnology
IPO Date
Jul 17, 2020
CEO
Eric Hobbs
Employees
230
Stock Exchange
NASDAQ
Ticker Symbol
BLI
Full Company Profile

Financial Performance

In 2020, BLI's revenue was $64.30 million, an increase of 13.42% compared to the previous year's $56.69 million. Losses were -$41.58 million, 127.2% more than in 2019.

Financial Statements

Analyst Forecasts

According to 5 analysts, the average rating for BLI stock is "Buy." The 12-month stock price forecast is 95.50, which is an increase of 104.23% from the latest price.

Price Target
$95.50
(104.23% upside)
Analyst Consensus: Buy